Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

"" Photograph by Nikhil Roshan
Press release
Press release |
14 January 2022
COVID-19

MSF responds to latest WHO recommendation for a COVID-19 therapeutic, baricitinib

3 min
MSF Medical Doctor, Mayard Mitial (R), and MSF Medical Doctor, Fenelon Jean (L), consult with a patient in St Yves. Photograph by Pierre Fromentin
Press release
Press release |
23 December 2021
COVID-19

MSF responds to FDA approval of COVID-19 drug molnupiravir

3 min
Treating COVID-19 second wave in South Africa Photograph by Chris Allan
Press release
Press release |
22 December 2021
COVID-19

MSF responds to FDA approval of COVID-19 treatment nirmatrelvir/ritonavir

5 min
"" Photograph by MSF
Press release
Press release |
10 December 2021
COVID-19

"Every day, we witness the failure of global solidarity"

3 min
On November 10, MSF held a demonstration in front of the White House in Washington, DC, calling on the Biden administration—which gave pharmaceutical corporations billions of US  taxpayer dollars to develop COVID-19 vaccines—to do more to ensure global vaccine equity. Photograph by Christopher Lee
Press release
Press release |
07 December 2021
COVID-19

One year after the first shot, pharma must urgently “share the tech” of COVID-19 vaccines

4 min
Atong Dut Deng, 8 years old, infected with cerebral malaria. She is being attended to by MSF medical staff in the ICU at MSF supported Aweil State Hospital. Photograph by Adrienne Surprenant
Press release
Press release |
02 December 2021
Malaria

MSF responds to Gavi board approving investment in malaria vaccine rollout

3 min
TRIPS waiver now!
Press release
Press release |
29 November 2021
COVID-19

In the wake of postponement of WTO’s Ministerial, MSF underscores the urgency of adopting the TRIPS Waiver for people’s unhindered access to COVID-19 medical tools

4 min
COVID-19 testing Photograph by Pablo Garrigos
Press release
Press release |
23 November 2021
COVID-19

MSF welcomes the first open license of a COVID-19 test to WHO COVID-19 Technology Access Pool

4 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury